MLNT (Melinta Therapeutics—f/k/a CEMP) implements 1:5 reverse split in conjunction with closing of reverse merger (#msg-133699889): https://www.sec.gov/Archives/edgar/data/1461993/000119312517333062/d474802d8k.htm